The drug compound MK5442 is currently undergoing phase 2 clinical trials for the treatment of osteoporosis.The study focuses on treatment of osteoporosis in postmenopasual women aged 45-80, who have been previously treated with an oral bisphosphate.MK5442 has been shown to increase bone density and as a result reduce the progression osteoporosis.The study is being conducted by Merck and will end i
n 2011.For those interested in participating in trial or getting information on the
trial check reference below.
References
http://clinicaltrials.gov/ct2/show/NCT00996801?rcv_d=14&rank=8
4 comments:
Do men get osteoporosis or is it limited to women only?
i have heard of male forms of osteoperosis...however since the cause of osteoperosis is linked with female hormones oegestron, females contain more of this hormone and are therefore more likly to get osteoperosis......thats what i have been taught anyways....
I am confident you've got a great enthusiast following there.
rehab centers in georgia
I'm in no doubt coming back again to read these articles and blogs.
Drug addiction Atlanta
Post a Comment